| Name | 3,5-dimethylimidazole-4-carboxylic acid |
|---|---|
| Synonyms |
3,5-Dimethyl-3H-imidazol-4-carbonsaeure
1,4-dimethyl-1H-imidazole-5-carboxylic acid 1,4-dimethyl-5-imidazolecarboxylic acid 3,5-dimethyl-3H-imidazole-4-carboxylic acid 1H-Imidazole-5-carboxylic acid,1,4-dimethyl |
| Molecular Formula | C6H8N2O2 |
|---|---|
| Molecular Weight | 140.14000 |
| Exact Mass | 140.05900 |
| PSA | 55.12000 |
| LogP | 0.42670 |
| Symbol |
GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H315-H319-H335 |
| Precautionary Statements | P261-P305 + P351 + P338 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2933290090 |
|
~60%
78449-67-9 |
| Literature: Takeda Pharmaceutical Company Limited Patent: EP2530078 A1, 2012 ; Location in patent: Page/Page column 148 ; |
| Precursor 1 | |
|---|---|
| DownStream 1 | |
| HS Code | 2933290090 |
|---|---|
| Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |